Total Payments
$3,257
2024 Payments
$635.79
Companies
24
Transactions
125
Medicare Patients
30,922
Medicare Billing
$2.7M
Payment Breakdown by Category
Food & Beverage$3,169 (97.3%)
Education$88.00 (2.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,169 | 124 | 97.3% |
| Education | $88.00 | 1 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $565.25 | 25 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $343.50 | 14 | $0 (2023) |
| NeoTract Inc. | $329.18 | 3 | $0 (2020) |
| Astellas Pharma US Inc | $309.73 | 12 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $284.93 | 12 | $0 (2024) |
| PROCEPT BioRobotics Corporation | $243.87 | 2 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $241.17 | 11 | $0 (2024) |
| Myovant Sciences Inc. | $175.44 | 8 | $0 (2022) |
| PFIZER INC. | $104.30 | 6 | $0 (2023) |
| Teleflex LLC | $92.10 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $635.79 | 21 | Janssen Biotech, Inc. ($187.95) |
| 2023 | $977.60 | 39 | Janssen Biotech, Inc. ($221.96) |
| 2022 | $569.83 | 29 | Myovant Sciences Inc. ($110.91) |
| 2021 | $540.30 | 26 | Dendreon Pharmaceuticals LLC ($101.82) |
| 2020 | $191.05 | 5 | NeoTract Inc. ($103.99) |
| 2019 | $108.77 | 1 | NeoTract Inc. ($108.77) |
| 2018 | $145.62 | 3 | NeoTract Inc. ($116.42) |
| 2017 | $88.00 | 1 | Astellas Pharma US Inc ($88.00) |
All Payment Transactions
125 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $29.11 | General |
| Category: Oncology | ||||||
| 11/01/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $28.25 | General |
| Category: HORMONE THERAPY | ||||||
| 10/21/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Oncology | ||||||
| 09/19/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $30.58 | General |
| Category: Oncology | ||||||
| 08/13/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $26.51 | General |
| Category: UROLOGY | ||||||
| 08/06/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $28.78 | General |
| Category: HORMONE THERAPY | ||||||
| 07/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Oncology | ||||||
| 07/16/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: Oncology | ||||||
| 06/04/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: Oncology | ||||||
| 05/30/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: Oncology | ||||||
| 05/22/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: HORMONE THERAPY | ||||||
| 05/02/2024 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | Cash or cash equivalent | $14.79 | General |
| Category: ONCOLOGY | ||||||
| 04/30/2024 | Boston Scientific Corporation | GreenLight XPS (Device) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: GreenLight_URO | ||||||
| 04/26/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $26.86 | General |
| Category: UROLOGY | ||||||
| 04/04/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: Oncology | ||||||
| 02/29/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $147.11 | General |
| Category: UROLOGY | ||||||
| 02/22/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $32.77 | General |
| Category: Oncology | ||||||
| 02/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Oncology | ||||||
| 02/08/2024 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | Cash or cash equivalent | $17.65 | General |
| Category: ONCOLOGY | ||||||
| 02/05/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: HORMONE THERAPY | ||||||
| 01/11/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $29.98 | General |
| Category: Oncology | ||||||
| 12/06/2023 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/30/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Oncology | ||||||
| 11/16/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Oncology | ||||||
| 10/19/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $27.76 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 45 | 8,609 | 16,119 | $3.3M | $758,293 |
| 2022 | 41 | 7,921 | 18,866 | $3.4M | $754,734 |
| 2021 | 51 | 8,163 | 17,115 | $3.3M | $742,132 |
| 2020 | 49 | 6,229 | 10,234 | $2.1M | $452,951 |
Total Patients
30,922
Total Services
62,334
Medicare Billing
$2.7M
Procedure Codes
186
All Medicare Procedures & Services
186 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,278 | 1,887 | $832,495 | $203,670 | 24.5% |
| J1952 | Leuprolide injectable, camcevi, 1 mg | Office | 2023 | 26 | 1,764 | $506,127 | $117,265 | 23.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 813 | 1,174 | $367,451 | $93,033 | 25.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 183 | 245 | $237,897 | $56,352 | 23.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 12 | 2,100 | $102,564 | $38,503 | 37.5% |
| 52648 | Complete laser vaporization of prostate including control of bleeding using an endoscope | Facility | 2023 | 49 | 49 | $283,415 | $32,595 | 11.5% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 374 | 422 | $88,299 | $22,822 | 25.8% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 58 | 59 | $77,009 | $20,749 | 26.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 1,346 | 1,996 | $96,299 | $20,152 | 20.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 175 | 175 | $68,948 | $16,617 | 24.1% |
| 55899 | Other procedure on male genital system | Office | 2023 | 40 | 40 | $52,210 | $10,734 | 20.6% |
| 51703 | Complicated insertion of bladder tube | Office | 2023 | 26 | 66 | $35,333 | $9,309 | 26.3% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 48 | 49 | $33,864 | $9,283 | 27.4% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 16 | 63 | $47,738 | $8,862 | 18.6% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 540 | 728 | $118,815 | $8,778 | 7.4% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 67 | 67 | $33,188 | $8,495 | 25.6% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 358 | 470 | $25,930 | $8,469 | 32.7% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 31 | 31 | $29,014 | $7,217 | 24.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 1,198 | 1,764 | $18,416 | $5,980 | 32.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $21,407 | $5,300 | 24.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 38 | 67 | $18,072 | $4,828 | 26.7% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 45 | 64 | $37,745 | $4,798 | 12.7% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 11 | 11 | $15,786 | $4,524 | 28.7% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 337 | 548 | $13,267 | $4,335 | 32.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 35 | 35 | $15,626 | $4,161 | 26.6% |
About Dr. Robert Luntz, MD
Dr. Robert Luntz, MD is a Urology healthcare provider based in Plainview, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1609869361.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Luntz, MD has received a total of $3,257 in payments from pharmaceutical and medical device companies, with $635.79 received in 2024. These payments were reported across 125 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($3,169).
As a Medicare-enrolled provider, Luntz has provided services to 30,922 Medicare beneficiaries, totaling 62,334 services with total Medicare billing of $2.7M. Data is available for 4 years (2020–2023), covering 186 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Plainview, NY
- Active Since 08/29/2005
- Last Updated 04/14/2011
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1609869361
Products in Payments
- ERLEADA (Drug) $565.25
- PROVENGE (Drug) $343.50
- ORGOVYX (Drug) $335.09
- UroLift (Device) $329.18
- Nubeqa (Drug) $241.17
- GEMTESA (Drug) $215.83
- XTANDI (Drug) $180.35
- AQUABEAM SYSTEM (Device) $147.11
- ELIGARD (Drug) $117.48
- AQUABEAM ROBOTIC SYSTEM (Device) $96.76
- Xtandi (Drug) $83.00
- UROLIFT (Device) $74.48
- KEYTRUDA (Biological) $61.44
- XIAFLEX (Biological) $46.57
- Myrbetriq (Drug) $42.89
- SpeediCath (Device) $40.62
- XGEVA (Biological) $37.97
- PYLARIFY (Drug) $26.30
- PROLARIS (Device) $23.94
- BOTOX (Biological) $21.98
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Plainview
Alfred Kohan, Md, MD
Urology — Payments: $69,017
Urology $69,017
Theodore Felderman, Md, MD
Urology — Payments: $12,450
Urology $12,450
Jeffrey Layne, Md, MD
Urology — Payments: $4,391
Urology $4,391
Dr. Jeffrey Haberman, Md, MD
Urology — Payments: $3,717
Urology $3,717
Dr. Tso-Jen Hsiao, M.d, M.D
Urology — Payments: $352.10
Urology $352.10
Dr. Elliott Lieberman, M.d, M.D
Urology — Payments: $349.79
Urology $349.79